Eugenia Ortega

Mutations in BRIP1 confer high risk of ovarian cancer

Daníel F. Guðbjartsson, Patrick Sulem, Áslaug Jónasdóttir et al. · Nature Genetics · 2011 · 427 citations

Medicine, Genetics, Molecular Genetics +11

Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus

Simon Stacey, Patrick Sulem, Carlo Zanon et al. · PLoS Genetics · 2010 · 106 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Lorena Alonso‐Alconada, Laura Muinelo‐Romay, Kadri Madissoo et al. · Molecular Cancer · 2014 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +17

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Gemcitabine/Capecitabine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

Beth Andres, José Mayordomo, Ricardo Lara et al. · Clinical Breast Cancer · 2005 · 27 citations

Medicine, Oncology, Pharmacology +12